Blog

Introducing LooporaData: The Commercialization Layer for Rare Healthcare Data

Why we are building infrastructure so rare healthcare datasets can be accessed in place — LooporaData never receives a copy.

Editor's note: Originally published Oct 2025, updated Apr 2026 and Aug 2026 for accuracy.

Move the value, not the data.

The LooporaData Thesis

Everyone talks about AI transforming healthcare. But there's a problem: the breakthrough models need breakthrough data, and that data is locked away. Researchers lose years chasing datasets for antibody prediction and rare disease trials. Clinical algorithms can't validate without diverse patient populations. Digital pathology AI remains limited by datasets that lack global representation. The bottleneck in medical progress isn't compute or algorithms; it's access to the data that makes them useful.

LooporaData exists to unlock that data. We built the commercialization layer that lets health systems, biobanks, and research institutes turn rare clinical and genomic datasets into timely, activated, revenue-ready assets — accessed in place, so the underlying data never has to move and LooporaData never receives a copy. Therapies that once took decades can reach patients in years. Rare disease treatments that might never find validation can access the cohorts they need. Precision medicine can finally deliver on its promise. All because the data finally becomes reachable.

We've watched research teams abandon promising drug candidates because they couldn't reach diverse patient cohorts. We've seen rare disease patients travel across the country because their local hospital lacks the data to validate treatment options. We've talked to clinicians who know AI could improve diagnostics, but can't get the diverse, annotated datasets they need. Many of us have felt the frustration of valuable medical data sitting idle — not because it's useless, but because there's no way to reach it without copying it, and no institution wants to give that up.

Our mission is straightforward: dismantle healthcare data silos, keep governance with the institutions that hold the data, and accelerate medical breakthroughs.

Why Now

Recent shifts make our timing right. Pharma data-licensing spend rose 37% in the first half of 2025 (IQVIA), and a single well-characterized-data deal cleared $2B (Alnylam–Inceptive) — real evidence that well-governed access to rare data commands real value. Generative AI has created unprecedented demand for high-quality medical data, but healthcare organizations still struggle with data quality, integration, and compliance. New regulations are forcing transparency: HIPAA interoperability rules and CMS prior authorization requirements are dismantling the old walls. Health systems that can't adapt risk falling behind.

Meanwhile, the competition is trapped in narrow lanes. HealthVerity serves pharma companies. Datavant connects health systems. Snowflake and Databricks provide infrastructure but charge extra for healthcare compliance and leave institutional control to someone else. Nobody is building for the multi-stakeholder reality where custodians, researchers, hospitals, and biotech companies all need reach and control at the same time.

What Makes Us Different

Built for Medical AI, Not Retrofitted. We don't just move data; we deliver it AI-ready, accessed in place. Automated normalization of EHR data, standardized clinical formats (FHIR, HL7, DICOM), comprehensive medical metadata. We even capture negative clinical results — the failed trials most vendors ignore — because that's what makes models robust. When a researcher connects to LooporaData, they're getting intelligence-ready access, not raw orphan files or a copy they now have to secure themselves.

Use Cases Transforming Healthcare Today

Vaccine Development: From Pandemic Response to Routine Prevention. When COVID-19 hit, vaccine developers faced a critical challenge: limited access to diverse immunological data across populations. Traditional vaccine development takes 10–15 years partly because researchers can't quickly reach paired BCR repertoire data with structural and functional outcomes across different demographics, geographies, and genetic backgrounds. LooporaData enables real-time surveillance: during emerging outbreaks, we help institutions make immune response data, infection patterns, and genomic sequences reachable across health systems to inform vaccine design and public health response in weeks instead of months.

Clinical Diagnostics: AI That Actually Works in the Real World. The promise of AI diagnostics has been talked about for years, but most models fail in practice because they're trained on narrow datasets from a handful of academic centers. A pathology AI trained on data from three U.S. hospitals doesn't work reliably when deployed in rural India or urban Brazil. LooporaData helps here through:

• Global Pathology Networks: Diagnostic AI for cancer, infectious diseases, and rare conditions can be trained on truly representative data — different staining protocols, scanner types, patient populations, and disease presentations.
• Multimodal Diagnostic Intelligence: The best diagnoses don't come from imaging alone. LooporaData supports compliant access to pathology slides alongside radiology images, lab values, genetic markers, and clinical notes — enabling AI that reasons like experienced clinicians, considering all available evidence.
• Continuous Learning: As new diagnostic cases become reachable (with patient consent), algorithms can continuously improve. A dermatology AI that misses melanoma in darker skin tones gets better as more diverse training data becomes available — something that isn't possible when each institution's data stays locked away.

Precision Medicine: Personalizing Treatment at Scale. Precision medicine promises to match each patient with the treatment most likely to work for them. But it requires understanding how different combinations of genetics, environment, lifestyle, and disease characteristics respond to various interventions. No single institution has enough patients to power these insights — especially for rare conditions or uncommon genetic profiles. LooporaData makes this practical:

• Integrated Molecular and Clinical Data: Genomic sequences, proteomic profiles, imaging phenotypes, and longitudinal clinical outcomes become reachable together, so researchers can identify which genetic variants predict response to specific cancer therapies, which biomarkers indicate cardiovascular risk, or which combinations of factors suggest a patient will benefit from a particular intervention.
• Rare Disease Treatment Matching: For ultra-rare conditions affecting dozens or hundreds of patients globally, every data point matters. Physicians can compare a patient's molecular profile against known cases worldwide (with consent), finding treatment approaches that worked for similar patients even when published literature doesn't exist.
• Predictive Treatment Selection: Before starting an expensive, potentially toxic therapy, clinicians can use AI models trained on comprehensive patient data to predict likely response — pattern recognition across thousands of similar cases that no human could mentally integrate.
• Population Health at Individual Scale: Health systems can stratify their entire patient population by risk, identifying individuals who would benefit from preventive interventions before they become acutely ill, by making claims data, EHR records, social determinants, and genetic information reachable together.

Solving Critical Healthcare Bottlenecks

LooporaData addresses the data gaps limiting medical AI today:

• Antibody/Vaccine Development: Reach large, diverse immunological datasets that don't exist anywhere else
• Rare Diseases: Bring tiny patient cohorts across institutions together to enable clinical trials
• Digital Pathology: Reach globally representative, consistently annotated histology images
• Multimodal Records: Reach imaging, labs, genomics, and clinical notes together for precision medicine
• Clinical Trial Optimization: Reach structured, searchable trial data to predict outcomes and stratify patients

Transaction-Aligned, Not Fee-for-Storage. We win when our customers win. While some vendors charge upfront licensing fees regardless of outcome, LooporaData's commercial model is aligned to successful transactions — low friction to get started, and we share in the upside only when your data creates value. Pricing and terms are set per engagement; reach out and we'll walk you through it.

Engineering for Healthcare

The technical challenges are real. Healthcare data arrives in dozens of incompatible formats — HL7, FHIR, DICOM, proprietary EHR exports. Privacy requirements vary by jurisdiction and patient preference. Consent management is a distributed systems challenge when tracking millions of individual permissions across thousands of datasets.

Our engineering solves this through layered abstraction. At the data layer, we've built universal translators that work with anything from Epic to Cerner to research databases and output standardized, AI-optimized formats. At the access layer, buyers bring their own environment to where the data lives — accessed in place, and LooporaData never receives a copy. Controls are designed to prevent copying or export. Access is logged and monitoring is applied.

Every action is auditable. Every dataset carries complete provenance. Every algorithm accessing data goes through safety checks. The result is infrastructure that clinicians trust, IRBs approve, and institutions feel confident using.

Proof on the Ground

We're early, but the signal is unmistakable.

One researcher told us: "We spent eighteen months trying to license clinical trial data for our algorithm validation. With LooporaData, we can have AI-ready access in three weeks." That's the gap we're closing — not between good and great research, but between great research and no research at all.

What's Next

Year One: Foundation

We are building the core infrastructure, proving the model with committed early partners in biomedical research, and establishing our beachhead in rare disease and immunology data. The goal: our system live and processing real research workflows.

Year Two: Healthcare Scale

Expand to digital pathology and multimodal patient records. Sign partnerships with major health systems, pharma companies, and academic medical centers. Launch clinical trial optimization tools. Scale to support thousands of research projects.

Year Three: Healthcare Leadership

Become the standard infrastructure for commercializing healthcare data — accessed in place. Enable precision medicine at scale. Build the ecosystem where medical AI developers, clinical researchers, and pharmaceutical companies all work from the same secure, well-governed data foundation.

Our Opportunity

This isn't incremental improvement. We're not building a better EMR or a faster database. We're creating the connective tissue for the next generation of medical breakthroughs — where AI models can reach the diverse, quality data they need, where researchers collaborate across institutional boundaries, where institutions keep governance over their own information, and where healthcare organizations realize the full value of their data assets.

The timing is right — AI demand plus regulatory tailwinds plus rising data-licensing spend — and the competition is stuck in vertical silos. With the right execution, LooporaData becomes infrastructure: the commercialization layer that makes medical AI actually work.

Build with us

Co-innovation: Do you want to unlock the terabytes and petabytes of proprietary medical data into more proficient and personalized health care?

Technical: If you're energized by solving hard infrastructure problems with real-world impact — if you want to build systems that accelerate drug discovery, enable precision medicine, and bring treatments to rare disease patients who have nowhere else to turn — we want to talk.

We're hiring across infrastructure engineering, healthcare data systems, compliance automation, and product. The problems are technically fascinating. The mission is urgent. The lives we can change are real.

Move the value, not the data.